3.63
3.63 (0%)
As of Feb 14, 2025
Lipocine Inc. [LPCN]
Source:
Company Overview
Lipocine Inc. is a biopharmaceutical company focused on leveraging our proprietary Lip’ral platform to develop differentiated products throughthe oral delivery of previously difficult to deliver molecules.
| Country | United States |
| Headquarters | salt lake city, utah |
| Phone Number | 801-994-7383 |
| Industry | manufacturing |
| CEO | Mahesh V. Patel |
| Website | www.lipocine.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $11.2 |
| Operating Profit | $-1.2 |
| Net Income | $0 |
| Net Cash | $1.4 |
Profit Ratios
| Gross Margin | $11.2 |
| Operating Margin | -10.3 |
| Profit as % of Revenues | 134,077.4% |
| Profit as % of Assets | 0% |
| Profit as % of Stockholder Equity | 0% |
Management Effectiveness
| Return on Equity | 0% |
| Return on Assets | 0% |
| Turnover Ratio | 49.2% |
| EBITA | $-1.2 |
Balance Sheet and Cash Flow Measures
| Total Assets | $22.5 |
| Total Liabilities | $1.5 |
| Operating Cash Flow | $-1.2 |
| Investing Cash Flow | $2.4 |
| Financing Cash Flow | $0.2 |
